Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt‐Koyanagi‐Harada disease
Acta Ophthalmologica · 2024
DOI: 10.1111/aos.16669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Ahmed M Abu El-Asrar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Uveomeningoencephalitic Syndrome, Regional Blood Flow, Oxygen, Choroid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia.
Abstract (Originalsprache)
Purpose
To investigate the association between pretreatment blood flow velocity in the choroid and optic nerve head (ONH) and retinal oxygen metabolism in the acute uveitic phase and the development of ‘sunset glow fundus’ in Vogt‐Koyanagi‐Harada (VKH) disease.
Methods
Retrospective analysis of 41 patients (82 eyes). Laser speckle flowgraphy and retinal oximetry measurements were performed at the presentation. The main outcome measure was the development of ‘sunset glow fundus’.
Results
Twenty patients (40 eyes) presented in the phase preceding anterior segment inflammation (early presentation), and 21 patients (42 eyes) presented with anterior segment inflammation (late presentation). In ONH, mean blur rate (MBR)‐vessel, representing blood flow velocity in retinal vessels, was significantly lower in the late presentation group, while choroidal MBR was not significantly different. The late presentation group had significantly lower oxygen saturation in retinal venules, a higher arteriovenous oxygen saturation difference and a smaller calibre of retinal arterioles compared with the early presentation group. Eyes that subsequently developed ‘sunset glow fundus’ had significantly lower ONH MBR‐vessels, lower oxygen saturation in retinal venules, a higher arteriovenous oxygen saturation difference and a smaller calibre of retinal arterioles compared with eyes without ‘sunset glow fundus’. ONH MBR‐vessel had a significant negative correlation with arteriovenous oxygen saturation difference and a significant positive correlation with calibre of retinal arterioles.
Conclusions
In the acute uveitic phase of VKH disease, the development of ‘sunset glow fundus’ is associated with pretreatment reduced retinal blood flow velocity, calibre of retinal arterioles and oxygen saturation in retinal venules, as well as an increased arteriovenous oxygen saturation difference.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Department of Ophthalmology and Physiology, University of Iceland, Reykjavik, Iceland.
ORCID-Profile: Ahmed M Abu El-Asrar, Abdulrahman F AlBloushi, Einar Stefánsson
Förderung
- Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
Zitieren
APA
Abu El-Asrar, A. M., AlBloushi, A. F., Alzubaidi, A., Gikandi, P. W., & Stefánsson, E. (2024). Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt‐Koyanagi‐Harada disease. Acta Ophthalmologica. https://doi.org/10.1111/aos.16669
Vancouver
Abu El-Asrar AM, AlBloushi AF, Alzubaidi A, Gikandi PW, Stefánsson E. Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt‐Koyanagi‐Harada disease. Acta Ophthalmologica. 2024. doi:10.1111/aos.16669
BibTeX
@article{AbuElAsrar2024,
author = {Abu El-Asrar, Ahmed M and AlBloushi, Abdulrahman F and Alzubaidi, Abdullah and Gikandi, Priscilla W and Stefánsson, Einar},
title = {Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt‐Koyanagi‐Harada disease},
journal = {Acta Ophthalmologica},
year = {2024},
doi = {10.1111/aos.16669}
}
EUVIMED